Agilent Technologies, Inc.
NYSE:AMedical - Diagnostics & Research
+$3.04 today
- Market cap
- $50.00B
- Beta
- 1.26
- P/E (TTM)
- 25.5
- EPS (TTM)
- $5.00
- Dividend yield
- 0.59%
Volume 2.48M
Average 2.24M
A Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Agilent Technologies, Inc.NYSE: A
Revenue · Q3 FY2026 · quarter ended Jul 2026
Revenue grows in line with its trailing trend
Q3 FY2026 revenue of $1.88B rose 8.1% year over year, behind the +8.6% change in trailing-twelve-month revenue. Sequentially, it rose 2.3% from the prior quarter. Over 3 fiscal years it compounded at +0.5% a year.
Context
- Revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 15 analysts of $7.5B (+7.9%) for the fiscal year ending Oct 2026, a step up from the +6.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJul 2026
- $1.88B+2.3% QoQ
- Last fiscal yearOct 2025
- $6.95B+6.7% YoY
- LTMJul 2026
- $7.37B+8.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +8.1% | +6.9% | -1.2 pp |
| 1 year | +6.7% | +7.9% | +1.2 pp |
| 3-year CAGR | +0.5% | +7.0% | +6.5 pp |
| 5-year CAGR | +6.2% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 6.95B USD
- Year-over-year change
- +6.7%
- 4-year CAGR
- +2.4%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-31 | 6.95B | +6.7% |
| FY2024 | 2024-10-31 | 6.51B | -4.7% |
| FY2023 | 2023-10-31 | 6.83B | -0.2% |
| FY2022 | 2022-10-31 | 6.85B | +8.4% |
| FY2021 | 2021-10-31 | 6.32B | — |
Revenue vs competitors
How A compares with its peers on the latest reported figures
- A's LTM Jul 2026 revenue of $7.37B is the 3rd highest of the 9 companies compared; the peer median is $3.82B.
- Its year-over-year change of +8.6% is the 2nd highest of 9, against a peer median of +4.8%.
- Over three fiscal years its annual growth of +0.5% compares with a peer median of -0.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $47.35B | +8.3% | -0.3% | |
| LTM Sep 2026 | $25.61B | +5.5% | -2.7% | |
| LTM Jul 2026 | $7.37B | +8.6% | +0.5% | |
| LTM Jul 2026 | $4.64B | +52.5% | +2.1% | |
| LTM Jun 2026 | $4.13B | +6.9% | +0.9% | |
| LTM Jun 2026 | $3.5B | +1.6% | +10.7% | |
| LTM Jul 2026 | $2.91B | +4.1% | -4.8% | |
| LTM Jun 2026 | $2.59B | +1.4% | -2.7% | |
| LTM Jun 2026 | $2.1B | +3.0% | -0.8% | |
| Peer median (excluding A) | $3.82B | +4.8% | -0.5% | |
Competitors are the stored peer set for A. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 6.32B | 6.85B | 6.83B | 6.51B | 6.95B |
| Cost of Revenue | 2.91B | 3.13B | 3.37B | 2.98B | 3.31B |
| Gross Profit | 3.41B | 3.72B | 3.47B | 3.54B | 3.64B |
| Gross Margin | 53.9% | 54.4% | 50.7% | 54.3% | 52.4% |
| Research & Development | 441M | 467M | 481M | 479M | 455M |
| Selling, General & Admin | 1.62B | 1.64B | 1.63B | 1.52B | 1.71B |
| Operating Expenses | 2.06B | 2.1B | 2.12B | 2.05B | 2.16B |
| Depreciation & Amortization | 321M | 317M | 271M | 257M | 288M |
| EBITDA | 1.76B | 1.91B | 1.7B | 1.87B | 1.84B |
| EBITDA Margin | 27.9% | 27.8% | 24.9% | 28.8% | 26.4% |
| Operating Income | 1.35B | 1.62B | 1.35B | 1.49B | 1.48B |
| Operating Margin | 21.3% | 23.6% | 19.8% | 22.9% | 21.3% |
| Interest Income | 2M | 9M | 51M | 80M | 62M |
| Interest Expense | 81M | 84M | 95M | 96M | 112M |
| Other Income / Expenses | 13M | (114M) | (11M) | 33M | (44M) |
| Income Before Tax | 1.36B | 1.5B | 1.34B | 1.52B | 1.44B |
| Pre-Tax Margin | 21.5% | 22.0% | 19.6% | 23.4% | 20.7% |
| Income Tax Expense | 150M | 250M | 99M | 232M | 132M |
| Net Income | 1.21B | 1.25B | 1.24B | 1.29B | 1.3B |
| Net Margin | 19.1% | 18.3% | 18.1% | 19.8% | 18.8% |
| EPS (Basic) | 3.98 | 4.19 | 4.22 | 4.44 | 4.59 |
| EPS (Diluted) | 3.94 | 4.18 | 4.19 | 4.43 | 4.57 |
| Weighted Avg Shares | 304M | 299M | 294M | 290M | 283M |
| Weighted Avg Shares (Diluted) | 307M | 300M | 296M | 291M | 284M |
Agilent Technologies, Inc.
NYSE:A
Intrinsic Alpha fair value
Locked
Current Price
$177.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.